• Date: January 08, 2019

CoverGel, one of the projects selected in CaixaImpulse 2018, has been awarded best project in the IDEA2 Global programme, a mentoring initiative developed by Massachusetts Institute of Technology (MIT). The programme recognises and supports highly innovative biomedical technologies, in order to help propel them into the market, and is sponsored by the Fundación para la Innovación y la Prospectiva en Salud en España (FIPSE), Cantabria Labs and Boston Landing.

Led at the Germans Trias I Pujol Research Institute, CoverGel proposes an innovative topical hydrogel for endoscopic therapeutic interventions that prevents complications such as perforations and bleeding. As part of the IDEA2 Global programme, 15 projects were selected to receive six months of specialised business mentoring.

More programme highlights

February 14, 2019

GlyCardial Diagnostics wins Horizon 2020 funding

Apo J-Glyc, a project selected in CaixaImpulse 2015, is now operating as a company named GlyCardial Diagnostics.

February 12, 2019

“The entrepreneur is the one who has to choose, whether they get it right or make mistakes”

Roger Gomis from IRB talks to us about what CaixaImpulse means to him and explains more about his role as mentor.

February 04, 2019

Applications open for CaixaImpulse’s 2019 call

CaixaImpulse is seeking 25 innovative health and biomedical projects to support and develop starting in 2019.